Thomas Stauffer Larsen

机构：University of Southern Denmark, Odense Municipality, Odense University Hospital · ORCID：0000-0002-8418-6708

发表论文 275 篇 · 总被引 4024 次 · h-index 37

代表论文

• Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial (2025 · Journal of Clinical Oncology · 被引 13)
• Biomarker‐adapted treatment in high‐risk large B‐cell lymphoma (2025 · HemaSphere · 被引 6)
• Monitoring ctDNA in aggressive B-cell lymphoma: a prospective correlative study of ctDNA kinetics and PET-CT metrics (2025 · Blood Advances · 被引 4)
• Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study (2025 · Blood Neoplasia · 被引 4)
• Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies (2025 · Blood Neoplasia · 被引 2)
• International Prognostic Models as Tools for Selection of Higher-risk Trial-eligible Patients With Diffuse Large B-Cell lymphoma (2025 · Clinical Lymphoma Myeloma & Leukemia · 被引 1)